B
BioAdvance
Micro VCActiveBioAdvance provides funding to life sciences startups and is a Pennsylvania-based venture capital firm.
185
Investments
2
Exits
$50M
AUM
1.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for BioAdvance.
Investment Thesis & Strategy
BioAdvance is a Pennsylvania-based micro-VC firm that invests in life sciences startups across various stages. They seek to fund companies in the biotech and life science industries.
Investment Activity
Deals per year over the last 10 years
1
20131
20141
20151
20161
20170
20180
20190
20201
20211
2022Portfolio Companies
Selected investments from their portfolio of 185 companies
V
Vaxcell Bio
Biotech · Series A, 2022
E
Exo Therapeutics
Biotech · Series B, 2021
C
Carisma Therapeutics
Biotech · Series A, 2017
V
Vivonics
Healthcare · Seed, 2016
C
Crosslink Orthopaedics
Healthcare · Seed, 2015
B
BioBots
Biotech · Seed, 2014
O
Optofluidics
Biotech · Seed, 2013
Notable Exits
CompanyTypeYearValue / Acquirer
Spark TherapeuticsAcquisition2019$4.3B
VaximmunAcquisition2015—
Frequently Asked Questions
BioAdvance focuses on Seed, Series A stage investments.
Related Investors
Dorm Room Fund
Philadelphia, United States · 147 deals
MentorTech Ventures
Philadelphia, United States · 43 deals
Chestnut Street Ventures
Philadelphia, United States · 40 deals
Rittenhouse Ventures
Philadelphia, United States · 29 deals
SRI Capital
Philadelphia, United States · 25 deals
StartUp PHL
Philadelphia, United States · 16 deals